Trial Profile
Conventional Step-Up Versus Infliximab Monotherapy in Patients With Active Moderate to Severe Ulcerative Colitis. A Randomized, Open Label, Prospective, Multicenter Study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Prednisolone (Primary) ; Azathioprine; Infliximab; Mesalazine
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms MUNIX
- Sponsors Merck Sharp & Dohme Corp.
- 18 Apr 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 18 Apr 2012 Actual patient number is 28 according to ClinicalTrials.gov.
- 10 Apr 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.